BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Slowing HEART diSease With Lifestyle and Omega-3 Fatty Acids

Not Applicable

Completed

Conditions: Metabolic Syndrome
Coronary Heart Disease

Interventions: Dietary Supplement: Omega 3 acid ethyl esters

First Posted Date: 2012-06-21

Last Posted Date: 2017-09-27

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 338

Registration Number: NCT01624727

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
South Shore Medical Group, Milton, Massachusetts, United States

Mindfulness Based Stress Reduction for Adults With Mild Cognitive Impairment

Not Applicable

Completed

Conditions: Mild Cognitive Impairment

Interventions: Behavioral: Mindfulness Based Stress Reduction (MBSR)

First Posted Date: 2012-05-24

Last Posted Date: 2012-05-24

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 14

Registration Number: NCT01605448

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Scribes in the Emergency Department

Withdrawn

Conditions: Scribes in the Emergency Department

First Posted Date: 2012-05-16

Last Posted Date: 2017-01-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT01599910

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)

Phase 2

Withdrawn

Conditions: Parkinson Disease
Amyotrophic Lateral Sclerosis

Interventions: Drug: Incobotulinum Toxin A
Drug: placebo

First Posted Date: 2012-03-28

Last Posted Date: 2017-02-07

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT01565395

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

Phase 4

Completed

Conditions: Hunger
Diabetes
Effects of Liraglutide Administration on Brain Activity
Weight Loss

Interventions: Drug: Liraglutide
Drug: Placebo

First Posted Date: 2012-03-26

Last Posted Date: 2017-05-31

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 28

Registration Number: NCT01562678

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Brain Imaging, Cognitive Enhancement and Early Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Behavioral: Enriched Supportive Therapy
Behavioral: Cognitive Enhancement Therapy

First Posted Date: 2012-03-23

Last Posted Date: 2021-02-26

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 102

Registration Number: NCT01561859

Locations: 🇺🇸
Massachusetts General Hospital, Charlestown, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts Institute of Technology, Cambridge, Massachusetts, United States

and more 2 locations

Seizure Activity in Alzheimer's Disease

Not Applicable

Completed

Conditions: Alzheimer's Disease
Seizures

Interventions: Drug: Low/High/Placebo Dose Keppra (Levetiracetam)

First Posted Date: 2012-03-15

Last Posted Date: 2020-07-23

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 12

Registration Number: NCT01554683

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Device: Repetitive Transcranial Magnetic Stimulation

First Posted Date: 2012-03-13

Last Posted Date: 2018-04-12

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 22

Registration Number: NCT01551979

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD)

Phase 2

Completed

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Behavioral: Mind-body breathing
Behavioral: Tai chi
Behavioral: Education

First Posted Date: 2012-03-13

Last Posted Date: 2017-02-27

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 124

Registration Number: NCT01551953

Locations: 🇺🇸
VA Healthcare System, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans

Not Applicable

Completed

Conditions: Intestinal FDG Uptake

Interventions: Drug: Rifaximin

First Posted Date: 2012-03-02

Last Posted Date: 2017-12-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 68

Registration Number: NCT01542541

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy